240 related articles for article (PubMed ID: 32899900)
1. Gateways for Glutamate Neuroprotection in Parkinson's Disease (PD): Essential Role of EAAT3 and NCX1 Revealed in an In Vitro Model of PD.
Piccirillo S; Magi S; Preziuso A; Castaldo P; Amoroso S; Lariccia V
Cells; 2020 Sep; 9(9):. PubMed ID: 32899900
[TBL] [Abstract][Full Text] [Related]
2. Glutamate as a potential "survival factor" in an in vitro model of neuronal hypoxia/reoxygenation injury: leading role of the Na
Piccirillo S; Castaldo P; Macrì ML; Amoroso S; Magi S
Cell Death Dis; 2018 Jun; 9(7):731. PubMed ID: 29955038
[TBL] [Abstract][Full Text] [Related]
3. NCX1 and EAAC1 transporters are involved in the protective action of glutamate in an in vitro Alzheimer's disease-like model.
Magi S; Piccirillo S; Maiolino M; Lariccia V; Amoroso S
Cell Calcium; 2020 Nov; 91():102268. PubMed ID: 32827867
[TBL] [Abstract][Full Text] [Related]
4. Physical and functional interaction of NCX1 and EAAC1 transporters leading to glutamate-enhanced ATP production in brain mitochondria.
Magi S; Lariccia V; Castaldo P; Arcangeli S; Nasti AA; Giordano A; Amoroso S
PLoS One; 2012; 7(3):e34015. PubMed ID: 22479505
[TBL] [Abstract][Full Text] [Related]
5. Essential role of the Na
Maiolino M; Castaldo P; Lariccia V; Piccirillo S; Amoroso S; Magi S
Sci Rep; 2017 Oct; 7(1):13073. PubMed ID: 29026150
[TBL] [Abstract][Full Text] [Related]
6. Glutamate-induced ATP synthesis: relationship between plasma membrane Na+/Ca2+ exchanger and excitatory amino acid transporters in brain and heart cell models.
Magi S; Arcangeli S; Castaldo P; Nasti AA; Berrino L; Piegari E; Bernardini R; Amoroso S; Lariccia V
Mol Pharmacol; 2013 Oct; 84(4):603-14. PubMed ID: 23913256
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of mitochondrial sodium-calcium exchanger protects striatal neurons from α-synuclein plus rotenone induced toxicity.
Bastioli G; Piccirillo S; Castaldo P; Magi S; Tozzi A; Amoroso S; Calabresi P
Cell Death Dis; 2019 Jan; 10(2):80. PubMed ID: 30692508
[TBL] [Abstract][Full Text] [Related]
8. NCX and EAAT transporters in ischemia: At the crossroad between glutamate metabolism and cell survival.
Piccirillo S; Magi S; Castaldo P; Preziuso A; Lariccia V; Amoroso S
Cell Calcium; 2020 Mar; 86():102160. PubMed ID: 31962228
[TBL] [Abstract][Full Text] [Related]
9. Punicalagin increases glutamate absorption in differentiated Caco-2 cells by a mechanism involving gene expression regulation of an EAAT3 transporter.
Biolley C; Tretola M; Bee G; Jud C; Silacci P
Food Funct; 2019 Sep; 10(9):5333-5338. PubMed ID: 31389458
[TBL] [Abstract][Full Text] [Related]
10. Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson's disease.
Plaitakis A; Shashidharan P
J Neurol; 2000 Apr; 247 Suppl 2():II25-35. PubMed ID: 10991662
[TBL] [Abstract][Full Text] [Related]
11. NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson's Disease.
Sirabella R; Sisalli MJ; Costa G; Omura K; Ianniello G; Pinna A; Morelli M; Di Renzo GM; Annunziato L; Scorziello A
Cell Death Dis; 2018 Jun; 9(7):725. PubMed ID: 29941946
[TBL] [Abstract][Full Text] [Related]
12. ATP-sensitive potassium channel opener iptakalim protected against the cytotoxicity of MPP+ on SH-SY5Y cells by decreasing extracellular glutamate level.
Hu LF; Wang S; Shi XR; Yao HH; Sun YH; Ding JH; Liu SY; Hu G
J Neurochem; 2005 Sep; 94(6):1570-9. PubMed ID: 16000145
[TBL] [Abstract][Full Text] [Related]
13. The dual face of glutamate: from a neurotoxin to a potential survival factor-metabolic implications in health and disease.
Magi S; Piccirillo S; Amoroso S
Cell Mol Life Sci; 2019 Apr; 76(8):1473-1488. PubMed ID: 30599069
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K.
Choong CJ; Say YH
Neurotoxicology; 2011 Dec; 32(6):857-63. PubMed ID: 21658409
[TBL] [Abstract][Full Text] [Related]
15. TNFR1 mediates increased neuronal membrane EAAT3 expression after in vivo cerebral ischemic preconditioning.
Pradillo JM; Hurtado O; Romera C; Cárdenas A; Fernández-Tomé P; Alonso-Escolano D; Lorenzo P; Moro MA; Lizasoain I
Neuroscience; 2006; 138(4):1171-8. PubMed ID: 16442237
[TBL] [Abstract][Full Text] [Related]
16. Prion protein regulates glutathione metabolism and neural glutamate and cysteine uptake via excitatory amino acid transporter 3.
Guitart K; Loers G; Schachner M; Kleene R
J Neurochem; 2015 May; 133(4):558-71. PubMed ID: 25692227
[TBL] [Abstract][Full Text] [Related]
17. Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson's Disease.
Zhang Y; Tan F; Xu P; Qu S
Neural Plast; 2016; 2016():8941327. PubMed ID: 26981287
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Na+-coupled glutamate transporter EAAT3 and EAAT4 by AMP-activated protein kinase.
Sopjani M; Alesutan I; Dërmaku-Sopjani M; Fraser S; Kemp BE; Föller M; Lang F
J Neurochem; 2010 Jun; 113(6):1426-35. PubMed ID: 20218975
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of glutamate transporters under hypoxic conditions in vitro.
Hsu L; Rockenstein E; Mallory M; Hashimoto M; Masliah E
J Neurosci Res; 2001 Apr; 64(2):193-202. PubMed ID: 11288147
[TBL] [Abstract][Full Text] [Related]
20. YM-244769, a novel Na+/Ca2+ exchange inhibitor that preferentially inhibits NCX3, efficiently protects against hypoxia/reoxygenation-induced SH-SY5Y neuronal cell damage.
Iwamoto T; Kita S
Mol Pharmacol; 2006 Dec; 70(6):2075-83. PubMed ID: 16973719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
